Word: arens
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Halloween's resilience in the face of a recession would seem to make some sense. It's relatively cheap fun, and parents aren't about to steal candy from their babies by grounding trick-or-treating. The kiddies, however, aren't driving the growth. "Sales of adult items are surprisingly strong," says Nick Pardasani, CEO of costumes4less.com, an online retailer. "Children's costumes used to dominate. Now it's about half and half." Pardasani says his sales are up 40% this year. Michael Jackson, Bernie Madoff and Kate Gosselin outfits are flying off the shelves, according to Spirit Halloween. (Read...
David Corbin, a chartered financial analyst and president of Corbin & Co. Capital Management, says he isn't surprised by the survey's results. "I'm actually surprised that the numbers aren't higher," he says. (Read about a study on why older workers are happier...
...icebreaker. It's even an icebreaker now in many ways. I was on an airplane coming back from Europe two days ago, and I didn't have on a pin because it doesn't work with security. And people would come up and say, "Why aren't you wearing a pin today?" So it's kind of become a thing. And I love to have people come up to talk to me, so it makes it more conversational and approachable...
Attorney Richard O'Brien, who is representing Northwestern in the case, says any idea that the school's student journalists aren't entitled to the same protections as working reporters is flawed. "It's not as traditional a platform as the New York Times or the Chicago Tribune, but I don't think anyone pretends that online journalism isn't journalism these days," O'Brien says. A judge is scheduled to hear arguments on the subpoena...
...biologics companies are still years away from seeing their first profits in this high-risk, high-return business. Their trade association, BIO, says that in the past 11 months, at least 40 of them have cut back or eliminated drug-development programs. The venture capitalists who invest in them "aren't looking to cure Parkinson's disease as much as they are looking for a return on their investments," says Greenwood. "They're just as happy to put their money into the next iPod." But increasingly, the big players in the pharmaceutical industry are moving into the biologics business themselves...